Amlodipine Besylate Tablet
Product Images NDC 71610-469

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0469 30)

Label for amlodipine besylate 10 mg oral tablets, provided in a package containing 30 tablets. The label includes storage instructions to keep the product between 20-25 degrees Celsius and dispense in a tight light-resistant container. The product is manufactured by Greenstone LLC and packaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label also shows the NDC number 71610-0469-30 and indicates it is for prescription use only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Amlodipine 01)

Chemical structure diagram of amlodipine besylate showing its molecular framework, including chlorine and amine functional groups.*

FDA Label Image

Figure 1 (Amlodipine 02)

A Kaplan-Meier survival curve comparing event rates over a 24-month period between two groups labeled Amlodipine and Placebo. The x-axis shows time in months, and the y-axis represents event rate. The graph includes a hazard ratio of 0.691, p-value 0.003, and confidence interval (0.54, 0.88), indicating statistical analysis of outcomes.*

FDA Label Image

Figure 2 (Amlodipine 03)

A forest plot illustrating hazard ratios with 95% confidence intervals for various patient subgroups in a study comparing amlodipine versus placebo. The subgroups include overall patients, age groups (<85 and ≥85), gender, baseline sitting systolic blood pressure, baseline vessel disease status, vessels with stenosis, and PCI-stent status. The plot shows which treatment favors either amlodipine or placebo along a horizontal axis ranging from 0 to 2.*

FDA Label Image

Logo (Amlodipine 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.